| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $266K | +8.0% |
| SG&A Expense | $5.6M | +260.6% |
| Operating Income | -$5.9M | -226.0% |
| Net Income | -$3.2M | -80.6% |
| EPS (Basic) | -$0.12 | -71.4% |
| EPS (Diluted) | -$0.12 | -71.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.0M | +708.3% |
| Current Assets | $5.2M | +373.3% |
| Total Assets | $12.2M | +493.6% |
| Current Liabilities | $6.0M | +748.0% |
| Total Liabilities | $7.5M | +235.8% |
| Stockholders' Equity | $4.7M | +2741.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.6M | -88.3% |
| Investing Cash Flow | -$153K | -53.8% |
| Financing Cash Flow | $6.9M | +500.4% |